Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ROCL
4076
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $101K | ﹤0.01% |
10,000
| – | – |
|
4077
Mercer International
MERC
$42.3M
| $101K | ﹤0.01% |
8,682
-67
| -0.8% | -$891 |
|
|
WW
4078
DELISTED
WW International
WW
| $101K | ﹤0.01% |
26,095
-5,167
| -17% | -$20.7K |
|
4079
Phathom Pharmaceuticals
PHAT
$708M
| $99.6K | ﹤0.01% |
8,879
+7,903
| +810% | +$81.5K |
|
4080
Quantum-Si Incorporated
QSI
$155M
| $99.3K | ﹤0.01% |
54,285
+18,954
| +54% | +$48.8K |
|
4081
Preformed Line Products
PLPC
$1.75B
| $99.2K | ﹤0.01% |
1,191
+566
| +91% | +$46.7K |
|
4082
CALL
Strategy Inc
MSTR
$34.1B
| $99.1K | ﹤0.01% |
+7,000
| New | +$143K |
|
|
STER
4083
DELISTED
Sterling Check Corp. Common Stock
STER
| $98.7K | ﹤0.01% |
6,378
+5,354
| +523% | +$86.5K |
|
|
CANO
4084
DELISTED
Cano Health, Inc.
CANO
| $98.6K | ﹤0.01% |
720
-15,684
| -96% | -$5.31M |
|
4085
First Community Corp
FCCO
$321M
| $98.6K | ﹤0.01% |
4,505
-188
| -4% | -$3.66K |
|
4086
Aspen Aerogels
ASPN
$384M
| $98.5K | ﹤0.01% |
8,353
+7,049
| +541% | +$80.6K |
|
|
IIF
4087
Morgan Stanley India Investment Fund
IIF
$217M
| $98.4K | ﹤0.01% |
+4,000
| New | +$93.5K |
|
|
VISL
4088
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
| $98K | ﹤0.01% |
8,750
| – | – |
|
|
IGMS
4089
DELISTED
IGM Biosciences
IGMS
| $98K | ﹤0.01% |
5,761
+3,810
| +195% | +$76.2K |
|
4090
Nautilus Biotechnolgy
NAUT
$124M
| $97.8K | ﹤0.01% |
54,315
+10,778
| +25% | +$20.8K |
|
4091
PUT
Novavax
NVAX
$1.2B
| $97.7K | ﹤0.01% |
+9,500
| New | +$168K |
|
|
NGD
4092
DELISTED
New Gold Inc
NGD
| $97.5K | ﹤0.01% |
99,513
-2,400
| -2% | -$2.42K |
|
|
SRTA
4093
Strata Critical Medical Inc
SRTA
$434M
| $97.5K | ﹤0.01% |
27,238
+12,863
| +89% | +$55K |
|
4094
Peoples Financial Services
PFIS
$704M
| $97.5K | ﹤0.01% |
1,880
+1,583
| +533% | +$84.3K |
|
|
OLP
4095
One Liberty Properties
OLP
$530M
| $97.4K | ﹤0.01% |
4,382
+3,642
| +492% | +$83.4K |
|
4096
FRP Holdings
FRPH
$428M
| $96.9K | ﹤0.01% |
3,600
+3,032
| +534% | +$86.5K |
|
4097
Bridgewater Bancshares
BWB
$571M
| $96.9K | ﹤0.01% |
5,463
+4,184
| +327% | +$76.7K |
|
4098
Taysha Gene Therapies
TSHA
$1.68B
| $96.8K | ﹤0.01% |
44,013
-3,866
| -8% | -$7.83K |
|
4099
The Joint Corp
JYNT
$118M
| $96.8K | ﹤0.01% |
6,923
-2,386
| -26% | -$36.9K |
|
4100
Valaris Ltd Warrants
VAL.WS
$684M
| $96.6K | ﹤0.01% |
8,116
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.